[et_pb_section fb_built=”1″ admin_label=”section” _builder_version=”3.22″][et_pb_row column_structure=”1_2,1_2″ admin_label=”row” _builder_version=”3.25″ background_size=”initial” background_position=”top_left” background_repeat=”repeat”][et_pb_column type=”1_2″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_image src=”https://www.progeriaresearch.org/wp-content/uploads/2020/10/Cover-page-for-newsletter-500.jpg” title_text=”Cover-page-for-newsletter-500″ _builder_version=”4.4.7″][/et_pb_image][/et_pb_column][et_pb_column type=”1_2″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.4.7″ custom_margin=”5px||||false|false” z_index_tablet=”500″]

As we all navigate this uncertain time, our fight against Progeria remains steadfast. PRF staff and the clinical trial team have been working closely with our Progeria families around the world, to ensure their continued access to PRF’s vital services. Our programs have been operating at full capacity, as we continue to provide researchers with the tools they need to proceed full steam ahead to the cure!

[/et_pb_text][et_pb_button button_url=”https://www.progeriaresearch.org/wp-content/uploads/2020/10/1-NEWSLETTER_2020_FINAL-GI.pdf” url_new_window=”on” button_text=”View the Full 2020 Newsletter” _builder_version=”4.6.5″ background_layout=”dark” custom_margin=”5px||||false|false” z_index_tablet=”500″][/et_pb_button][/et_pb_column][/et_pb_row][/et_pb_section]